首页 › 基金 › Ranger Investment Management, L.P. › ANIP
Ranger Investment Management, L.P. 对 ANIP 的持仓历史
ANI PHARMACEUTICALS INC · 医疗保健
Ranger Investment Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 ANIP(ANI PHARMACEUTICALS INC)268,628 股,市值约 US$19.5M,约占其申报组合的 1.83%,在其申报持仓中市值排名第 13 位。 Ranger Investment Management, L.P. 最近 13 个申报季度中有 13 个季度披露了 ANIP 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Ranger Investment Management, L.P. 对 ANIP 的持仓演变
Ranger Investment Management, L.P. 于 Q3 2023 首次披露 ANIP 持仓:426,848 股(约 US$24.8M)。 该持仓在 Q1 2025 达到峰值 571,638 股,市值约 US$38.3M。 在 13 次申报中,Ranger Investment Management, L.P. 3 次增持、8 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 268,628 股、市值约 US$19.5M,环比减持 -74,522 股。。 持仓曾出现大幅变动:Q3 2024 增持约 46% (随后一个季度股价下跌 7%)、Q3 2025 减持约 49% (随后一个季度股价下跌 14%)、Q4 2025 增持约 34% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 426.85K | $24.78M | 新进 |
| Q4 2023 | 434.62K | $23.96M | 增持 |
| Q1 2024 | 402.20K | $27.80M | 减持 |
| Q2 2024 | 402.73K | $25.65M | 持有 |
| Q3 2024 | 589.69K | $35.18M | 增持 |
| Q4 2024 | 577.74K | $31.94M | 减持 |
| Q1 2025 | 571.64K | $38.27M | 减持 |
| Q2 2025 | 534.23K | $34.86M | 减持 |
| Q3 2025 | 271.35K | $24.86M | 减持 |
| Q4 2025 | 362.38K | $28.61M | 增持 |
| Q1 2026 | 360.08K | $27.69M | 减持 |
| Q2 2026 | 343.15K | $28.41M | 减持 |
| Q3 2026 | 268.63K | $19.52M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANIP 与 13F 数据
ANIP(ANI PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 ANIP,申报仓位最大的包括:Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Empyrean Capital Partners, LP (US$29.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANIP 的基金
- Soleus Capital Management, L.P. 867.76K 股 · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K 股 · $58.57M · Q2 2026
- Empyrean Capital Partners, LP 23.00M 股 · $29.75M · Q2 2026
- HBK INVESTMENTS L P 20.15M 股 · $26.12M · Q2 2026
- Ikarian Capital, LLC 272.08K 股 · $22.52M · Q2 2026
- Parkman Healthcare Partners LLC 202.91K 股 · $16.80M · Q2 2026
- Boussard & Gavaudan Investment Management LLP 13.35K 股 · $16.46M · Q1 2026
更多关于 Ranger Investment Management, L.P.
常见问题
How long has Ranger Investment Management, L.P. held ANIP?
Ranger Investment Management, L.P. has disclosed ANIP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Ranger Investment Management, L.P.'s current position in ANIP?
As of Q3 2026, Ranger Investment Management, L.P. holds 268.63K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $19.52M, representing 1.83% of its reported portfolio and ranking #13.
Has Ranger Investment Management, L.P. been buying or selling ANIP?
In the latest 13F filing (Q3 2026), Ranger Investment Management, L.P. reduced its position in ANIP. The position peaked in Q1 2025 at 571.64K shares.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Empyrean Capital Partners, LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.